Altimmune, Inc. (NASDAQ:ALT) Q2 2023 Earnings Call Transcript August 10, 2023 8:30 AM ET Company Participants Rich Eisenstadt - Chief Financial Officer Vipin Garg - Chief Executive Officer Scott Harris - Chief Medical Officer Scot Roberts - Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Roger Song - Jefferies Mayank Mamtani - B. Riley Securities Jon Wolleben - JMP Louis Susser - H. C. Wainwright Operator Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. ...